跳至主要内容
临床试验/JPRN-UMIN000033333
JPRN-UMIN000033333已完成未知

The prospective study of the preventive effect of supraorbital transcutaneous stimulation using the Cefaly(R) device against frequent episodic migraine and chronic migraine - The prospective study of the preventive effect of supraorbital transcutaneous stimulation using the Cefaly(R) device against frequent episodic migraine and chronic migraine

Tominaga Hospital0 个研究点目标入组 100 人开始时间: 2018年7月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)The subjects who changed their prophylaxis within the previous 3 months 2)The subjects who received BOTOX or a nerve block within the previous 3 months 3)The subjects with any secondary headache except for MOH 4)The subjects who have severe neurologic and/or psychiatric disorders 5)The subjects who have epilepsy 6)Pregnant or breast-feeding women 7)The subjects who have severe heart, liver, and/or renal dysfunction 8)The subjects who are using opioids 9)The subjects who have allodynia 10)The subjects who have metal and/or electrical device in their body 11)The subjects who are using cardiac pace-maker and/or implantable cardioverter-defibrillator 12)The subjects whom investigators estimate are not eligible

研究者

相似试验